MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,815,660 | -93.8% | 181,566 | -92.2% | 0.00% | -94.7% |
| Q2 2023 | $29,096,890 | -14.4% | 2,340,860 | -3.5% | 0.02% | -20.8% |
| Q1 2023 | $33,974,501 | +28.6% | 2,425,018 | +31.3% | 0.02% | +14.3% |
| Q4 2022 | $26,425,919 | -49.2% | 1,846,675 | -9.3% | 0.02% | -43.2% |
| Q3 2022 | $51,998,000 | +21.6% | 2,036,754 | +35.3% | 0.04% | +15.6% |
| Q2 2022 | $42,772,000 | -20.5% | 1,505,541 | -1.3% | 0.03% | -3.0% |
| Q1 2022 | $53,794,000 | +0.5% | 1,525,222 | +19.4% | 0.03% | +13.8% |
| Q4 2021 | $53,530,000 | +23.3% | 1,277,555 | +44.5% | 0.03% | +11.5% |
| Q3 2021 | $43,408,000 | +1855.3% | 884,422 | +1562.9% | 0.03% | +2500.0% |
| Q2 2021 | $2,220,000 | +670.8% | 53,185 | +557.3% | 0.00% | – |
| Q1 2021 | $288,000 | +1415.8% | 8,092 | +1113.2% | 0.00% | – |
| Q4 2020 | $19,000 | – | 667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |